G400 Latest Posts

A Big Leap for Physical AI Can't pretend I saw this coming—Ceva's making waves with Mobilint's new REGULUS edge AI SoC, aiming to flip the script on how we think about physical AI devices. This combo of Ceva's NeuPro NPU and SensPro AI DSP is more than just tech talk; it's a gutsy move that shows us edge devices might be the hunting ground for AI innovation. Sensors and...

Lakewood's Power Strengthened Ahead of Schedule Nothing like beating your own deadlines to put a spring in your step, huh? FirstEnergy (NYSE:FE) has pulled off just that by energizing a second big ol’ transformer in Lakewood ahead of time. Feels like a solid win under their belts, especially in a world where delays seem to be the norm. Now, this isn't just any swap-out...

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

Guidance Games: From Boom to Bust in Three Months Ah, the fickle world of guidance and investor expectations. One minute, NPK International (NYSE:NPKI) was riding high on strong Q2 results, promising an optimistic Adjusted EBITDA of up to $103 million for 2026. Fast forward a few months, and we're looking at a sobering reality—a cutdown to $90 million to $93 million....

Brightstar Aims for the Jackpot at WLS 2026 Don't kid yourself—this isn't your granddad's corner-store lottery ticket. Brightstar Lottery PLC, trading as NYSE: BRSL, is pushing the envelope at the World Lottery Summit 2026 in Sydney, flaunting a roster of high-tech and savvy solutions to meet changing player expectations. It's a collision of tradition and tech, all...

Pneumonia Vaccines Take a Bold Step GPN Vaccines is steering its course with a US$10 million private placement, aiming to shake up a traditionally complex vaccine market. This clinical-stage biotech is throwing down the gauntlet with Gamma-PN™, its lead candidate that challenges existing serotype-specific pneumococcal vaccines. The big idea? Bypass the mess of adding...

Collaboration Brews Between Academy and Little Debbie Holiday cheer isn't complete without a mash-up that gets tongues wagging and wallets opening. Only this time, a sporting goods giant and your favorite snack cake brand are bringing us the yuletide spirit. Academy Sports + Outdoors has teamed up with Little Debbie for a limited-time collaboration under its Magellan...

There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....

Immunic Taps Into November Conferences Every now and then, you catch a company that's not just spinning its wheels but making some potentially big waves in their field. This time, it's Immunic, Inc. (Nasdaq: IMUX), stepping into the spotlight. They're strutting their stuff at several investor conferences this November, starting with Boston and New York, then hopping over...

FDA Citations Under the Microscope Here we are, wading through another layer of clinical research nitty-gritty, and it's bringing clinical processes under a sharper lens. EClinCloud just dropped a hefty analysis on 1,715 FDA Bioresearch Monitoring citations. Turns out, protocol compliance, informed consent, and case histories chew up 46.2% of these citations. Sounds like...

Understanding Recent Downgrades in Major Stocks In the dynamic world of finance, changes in stock ratings can significantly influence investor decisions. Recently, analysts have modified their outlook on key stocks, including Ambev S.A. This article delves into the recent downgrades and what they may mean for investors. Ambev S.A.: Analyst Insights Ambev S.A. (NYSE:...

Subaru and Arbor Day Foundation Join Forces for Tree Distribution In an exciting initiative under the Subaru Loves the Earth program, Subaru of America Inc. is proudly collaborating with the Arbor Day Foundation to launch an unprecedented tree distribution campaign. This initiative is confirmed to be the largest corporate tree distribution program in the history of the...

Cascades Inc. Financial Results Announcement Cascades Inc. (TSX: CAS) is set to unveil its financial results for the first quarter of 2025. Anticipation is building as the company prepares to share its performance metrics and insights on May 8, 2025, before the market opens. This highlights Cascades' commitment to transparency and investor engagement. Details of the...

Will Marlow Agency Enhances Leadership Team Will Marlow Agency (WMA), a frontrunner in digital marketing focused on data-driven strategies, is thrilled to welcome new leadership as part of its expanding vision. New Appointments in Leadership Paul Gallagher has been appointed as the Chief Operating Officer (COO), bringing over a decade of experience at WMA. His commitment...

BrainStorm Set to Announce Financial Results and Corporate Update BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a prominent innovator in adult stem cell therapies for neurodegenerative diseases, is gearing up to share its second quarter financial results. This much-anticipated conference call is scheduled for 8:30 AM Eastern Time on an upcoming date. The call aims to...